CANCER-RELATED FATIGUE

被引：22

作者：

De Waele, S. ^{[1
]}

Van Belle, S. ^{[1
]}

机构：

[1] Ghent Univ Hosp, Dept Med Oncol, B-9000 Ghent, Belgium

来源：

ACTA CLINICA BELGICA | 2010年 / 65卷 / 06期

关键词：

cancer; fatigue; management; pharmacotherapy; QUALITY-OF-LIFE; PROPOSED DIAGNOSTIC-CRITERIA; DOUBLE-BLIND TRIAL; CLINICAL-TRIAL; PHASE-III; DEPRESSION; METHYLPHENIDATE; CHEMOTHERAPY; PATIENT; SUPPLEMENTATION;

D O I：

10.1179/acb.2010.65.6.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cancer-related fatigue (CRF) is the most commonly reported symptom in patients with cancer with a prevalence up to 100%. It has a significant negative impact on quality of life. An effective management of CRF could significantly reduce the disease burden associated with cancer and its treatment. Unfortunately, the underlying pathophysiology is very complex and not uniform. This article reviews the possible therapy of contributing factors, nonpharmacological treatment, such as exercise and psychosocial interventions, and pharmacologic approaches in managing CRF. Numerous drugs, such as psychostimulants (methylphenidate, dexamphetamines, modafinil and pemoline), antidepressants, corticosteroids, L-carnitine, donepezil and guarana have been studied. Methylphenidate, modafinil and guarana show the most promising results so far. However, additional randomized, placebo-controlled trials are needed to determine the benefit of these and other drugs in the treatment of CRF.

引用

页码：378 / 385

页数：8

共 56 条

[1]

[Anonymous], INT CLASSIFICATION D

[2] A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Impact of Dexamphetamine on Fatigue in Patients with Advanced Cancer [J].

Auret, Kirsten Anne ;

Schug, Stephan A. ;

Bremner, Alexandra P. ;

Bulsara, Max .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2009, 37 (04) :613-621

[3]

Berger Ann Malone, 2008, J Natl Compr Canc Netw, V6, P3

[4] Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial [J].

Bruera, E ;

Valero, V ;

Driver, L ;

Shen, LR ;

Willey, J ;

Zhang, T ;

Palmer, JL .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2073-2078

[5]

BRUERA E, 1985, CANCER TREAT REP, V69, P751

[6] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial [J].

Bruera, Eduardo ;

El Osta, Badi ;

Valero, Vicente ;

Driver, Larry C. ;

Pei, Be-Lian ;

Shen, Loren ;

Poulter, Valerie A. ;

Palmer, J. Lynn .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) :3475-3481

[7] A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCL in brain tumor patients receiving radiation therapy [J].

Butler, Jerome M., Jr. ;

Case, L. Douglas ;

Atkins, James ;

Frizzell, Bart ;

Sanders, George ;

Griffin, Patricia ;

Lesser, Glenn ;

Mcmullen, Kevin ;

Mcquellon, Richard ;

Naughton, Michelle ;

Rapp, Stephen ;

Stieber, Volker ;

Shaw, Edward G. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05) :1496-1501

[8]

CAMPOS MP, J CLIN ONCOL, V28, P9007

[9] Pharmacologic treatment of cancer-related fatigue [J].

Carroll, Jennifer K. ;

Kohli, Sadhna ;

Mustian, Karen M. ;

Roscoe, Joseph A. ;

Morrow, Gary R. .

ONCOLOGIST, 2007, 12 :43-51

[10] Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors [J].

Cella, D ;

Davis, K ;

Breitbart, W ;

Curt, G .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3385-3391

← 1 2 3 4 5 6 →